{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:08:46Z","timestamp":1786428526025,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2221-E-002-163-"],"award-info":[{"award-number":["108-2221-E-002-163-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["107-EDN11"],"award-info":[{"award-number":["107-EDN11"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["108-N4406"],"award-info":[{"award-number":["108-N4406"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["108-EDN02"],"award-info":[{"award-number":["108-EDN02"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejvs.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T08:35:33Z","timestamp":1564994133000},"page":"373-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia"],"prefix":"10.1016","volume":"58","author":[{"given":"Jenkuang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naichen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochih","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyhming","family":"Jimmy Juang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chokai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jueyjen","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunnlee","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futien","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiati","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2019.02.011_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor\u2019s choice - 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib2","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib3","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2010.11.024","article-title":"Clopidogrel-drug interactions","volume":"57","author":"Bates","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/pr.113.007781","article-title":"The pharmacology of the cytochrome P450 epoxygenase\/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease","volume":"66","author":"Fleming","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ejvs.2019.02.011_bib6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2125.2009.03578.x","article-title":"Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17","volume":"69","author":"Li-Wan-Po","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/HJH.0b013e32831fda3a","article-title":"Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure","volume":"27","author":"Wu","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejvs.2019.02.011_bib8","doi-asserted-by":"crossref","first-page":"d4588","DOI":"10.1136\/bmj.d4588","article-title":"Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis","volume":"343","author":"Bauer","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2019.02.011_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4244\/EIJV9I3A53","article-title":"The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation","volume":"9","author":"Liang","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ejvs.2019.02.011_bib10","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jvs.2014.03.293","article-title":"Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease","volume":"60","author":"Guo","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2217\/pgs-2016-0056","article-title":"Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty","volume":"17","author":"D\u00edaz-Villamar\u00edn","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejvs.2019.02.011_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejvs.2015.09.020","article-title":"Effect of CYP2C19 polymorphisms on the platelet response to clopidogrel and influence on the effect of high versus standard dose clopidogrel in carotid artery stenting","volume":"51","author":"Gonz\u00e1lez","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/CIRCULATIONAHA.112.001232","article-title":"Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease","volume":"127","author":"Kinlay","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2019.02.011_bib14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.jacc.2011.08.023","volume":"58","author":"Rooke","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1 Pt 2","key":"10.1016\/j.ejvs.2019.02.011_bib15","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-society Consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.thromres.2006.11.012","article-title":"Measuring antiplatelet drug effects in the laboratory","volume":"120","author":"Harrison","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2019.02.011_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0026-895X(25)09788-3","article-title":"Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese","volume":"46","author":"De Morais","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2012.03.022","article-title":"Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies","volume":"164","author":"Jeong","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejvs.2019.02.011_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2019.02.011_bib20","doi-asserted-by":"crossref","first-page":"17007","DOI":"10.1038\/srep17007","article-title":"Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejvs.2019.02.011_bib21","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/CCM.0b013e31820a91b9","article-title":"Plasma levels of tumor necrosis factor-\u03b1 and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase","volume":"39","author":"Wu","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejvs.2019.02.011_bib22","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jacc.2010.04.069","article-title":"Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey)","volume":"56","author":"Wu","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1475-2840-12-127","article-title":"Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis","volume":"12","author":"Lin","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib24","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacl.2017.08.018","article-title":"Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients","volume":"11","author":"Wu","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib25","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"Geisler","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2019.02.011_bib26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ejvs.2011.08.014","article-title":"On-treatment function testing of platelets and long-term outcome of patients with peripheral arterial disease undergoing transluminal angioplasty","volume":"42","author":"van der Loo","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejvs.2016.04.019","article-title":"High on-treatment platelet reactivity in peripheral arterial disease: a pilot study to find the optimal test and cut off values","volume":"52","author":"Leunissen","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib28","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet function monitoring in patients with coronary artery disease","volume":"50","author":"Gurbel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib29","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2012.11.080","article-title":"Platelet function tests in clinical cardiology: unfulfilled expectations","volume":"61","author":"Gorog","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejvs.2015.01.017","article-title":"Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis","volume":"49","author":"Shiraki","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002938","article-title":"Critical limb ischemia: current trends and future directions","volume":"5","author":"Teraa","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2019.02.011_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jvs.2010.12.055","article-title":"In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia","volume":"54","author":"Vogel","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jvs.2011.08.014","article-title":"Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions","volume":"55","author":"Iida","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib34","first-page":"830","article-title":"Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia","volume":"75","author":"Iida","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.02.011_bib35","first-page":"861","article-title":"Predictors of adverse clinical outcomes after successful infrapopliteal intervention","volume":"80","author":"Kawarada","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.02.011_bib36","first-page":"1051","article-title":"Assessment of macro- and microcirculation in contemporary critical limb ischemia","volume":"78","author":"Kawarada","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.02.011_bib37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jvs.2013.11.063","article-title":"Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes","volume":"59","author":"Mueller","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2261-5-14","article-title":"The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database","volume":"5","author":"Caro","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"issue":"Suppl 1","key":"10.1016\/j.ejvs.2019.02.011_bib39","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.02.011_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14140","volume":"14","author":"Bradbury","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ejvs.2019.02.011_bib41","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy \u2013 the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejvs.2019.02.011_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/jpm2040201","article-title":"Insurance coverage policies for personalized medicine","volume":"2","author":"Hresko","year":"2012","journal-title":"J Pers Med"},{"key":"10.1016\/j.ejvs.2019.02.011_bib43","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1008410","article-title":"Effects of CYP2C19 genotype on outcomes of clopidogrel treatment","volume":"363","author":"Par\u00e9","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2019.02.011_bib44","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2019.02.011_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2010.05.013","volume":"56","author":"Holmes","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588419301091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588419301091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:51:40Z","timestamp":1761047500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588419301091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1078588419301091"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2019.02.011","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society for Vascular Surgery. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}